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Introduction
Rheumatoid arthritis (RA) is a chronic immune inflammatory disease characterized by synovial hyperplasia, joint destruction and extra-articular manifestations, with significant impacts on both morbidity and mortality [1] . Although the aetiology and pathogenesis of this disease have not been elucidated fully, it is known that joint inflammation and damage in RA are mediated by the influx of innate and adaptive immune cells into the synovial joint space, such as neutrophils, macrophages, synovial fibroblasts, T cells and B cells [2] . Neutrophils are the most abundant immune cells present in synovial fluid from the joints of RA patients and are also abundant at the pannus/ cartilage interface, the site of active tissue damage [3] .
Neutrophils, terminally differentiated cells with a short lifespan in circulation, are the most abundant leucocytes in the human body, with homeostasis maintained by their continuous release from the bone marrow [4] . Complex interactions between receptors on neutrophils and vascular endothelial cells regulate their attachment and subsequent migration from the circulation into tissues during inflammation [5, 6] . Various functional abnormalities of neutrophils have been reported in RA [2] . Many clinical studies have revealed the pivotal contributions of cytokines in RA pathogenesis [7, 8] ; the critical roles of tumour necrosis factor (TNF) and interleukin (IL)-6 therein have been demonstrated unequivocally by successful clinical targeting of these cytokines in RA using biological therapies [9] . Neutrophil granule proteins, such as myeloperoxidase (MPO), matrix metalloproteinases (MMPs), neutrophil elastase (NE), cathepsin G and proteinase 3 [10] , are found in high concentrations in RA synovial fluid and may be responsible for damage to cartilage and tissue, activation of soluble cytokines and receptors, inhibition of chondrocyte proliferation and activation of synoviocyte proliferation and invasion [2] . Circulating and synovial fluid neutrophils in RA patients are more prone to form neutrophil extracellular traps (NETs) compared with neutrophils from healthy controls and from patients with osteoarthritis [11] . Levels of NETosis correlate with the presence and levels of anticitrullinated peptide antibodies (ACPAs) and markers of systemic inflammation [12, 13] . Furthermore, in RA, dysregulation of neutrophil apoptosis can lead to their extended survival in inflamed tissues, which prolongs the release of neutrophil-derived immune regulatory cytokines, chemokines and cytotoxic products and can lead to persistent inflammation [1, 2] . Therefore, neutrophils serve as important targets for RA therapy.
Tanshinone IIA (TIIA), a phenanthrenequinone derivative extracted from Salvia miltiorrhiza Bunge, has been used clinically to manage many diseases, such as angina pectoris, myocardial infarction and stroke [14] . Previous studies have demonstrated that TIIA may exert anti-inflammatory effects [15] [16] [17] . TIIA inhibits the production of proinflammatory mediators, such as nitric oxide (NO), TNF-a, IL-1b and IL-6 via the inhibition of nuclear factor kappa B (NF-jB) activation in RAW 264.7 cells stimulated with lipopolysaccharide (LPS) [15] . In brain microvascular endothelial cells, TIIA inhibits vascular cell adhesion protein 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) expression concentration-dependently through the inhibition of NF-jB activation and reactive oxygen species (ROS) generation induced by TNF-a [16] . TIIA also induces inflammation resolution in vivo by both the induction of neutrophil apoptosis and the promotion of neutrophil reverse migration [17] . However, whether or not TIIA can ameliorate chronic inflammation in RA remains largely unknown.
We hypothesized that TIIA reduced neutrophil infiltration and activation, which may eventually attenuate the inflammatory response in RA. We investigated whether treatment with TIIA could ameliorate adjuvant-induced arthritis in a murine model of RA.
Materials and methods

Animals
C57BL/6 female mice, 8 weeks of age, were purchased from Academy of Military Medical Sciences (Beijing, China). The mice were maintained in standard housing cages under specific pathogen-free conditions. All experimental procedures were reviewed and approved by the Beijing University of Chinese Medicine Animal Care and Use Committee and were in accordance with the institutional guidelines for the Care and Use of Laboratory Animals. 
Reagents
Murine model of adjuvant-induced arthritis
Chronic arthritis was induced by injection of FCA, as described previously [18] . Briefly, 20 and 80 ll of FCA (10 mg/ml heat-killed Mycobacterium tuberculosis, Sigma) was injected into the joint space and periarticular in mice, respectively. Joint swelling was assessed by measuring ankle joint diameter using a pocket thickness gauge (Mitutoyo, Kawasaki, Japan). Arthritis severity was graded on a scale of 0-4, as described previously [19] .
Histological analysis
For histological analysis, the ankle joints from mice were fixed in 4% paraformaldehyde, decalcified in 10% ethylenediamine tetraacetic acid (EDTA) solution, processed and embedded in paraffin. Four-lm-thick tissue sections were stained with haematoxylin and eosin (H&E) to characterize ankle joint injury under a microscope.
Immunohistochemistry
For the immunostaining of paraffin sections, 4-lm-thick ankle joint sections were deparaffinized with xylene and rehydrated with ethanol and water. Endogenous peroxidase activity was blocked with 3% H 2 O 2 for 15 min at room temperature. Antigen retrieval was accomplished in a microwave oven at 600 W for 15 min in 0Á01 M citrate buffer at pH 6Á0, which was rinsed later with phosphatebuffered saline (PBS). Sections were incubated with primary anti-MPO antibody and anti-NE antibody at 48C overnight. The sections were incubated with biotinylated HRP-conjugated goat anti-rabbit antibodies. The coloured product was developed by incubation with 3,3 0 -diaminobenzidine tetrahydrochloride dihydrate (DAB). Immunohistochemical staining was photographed with a light microscope. The intensity of the staining signal was measured and documented using the Image-Pro Plus version 6.0 image analysis software.
Air pouch experiments
Air pouch experiments were performed as described previously [20] . In brief, C57BL/6 mice (five mice per group) were anaesthetized with chloral hydrate and sterilized air (3 ml filtered through a 0Á22 lm Millipore filter; Millipore, Billerica, MA, USA) was given via subcutaneous injection in the back using a 26-gauge needle to make an air pouch on days 0 and 3. On day 6, 1 ml of buffer (Ctrl) and 1 lg/ ml of LPS (positive control) with or without 25 lM TIIA was injected into the air pouches of mice 6 h before the mice were killed by CO 2 asphyxiation. The air pouches were washed once with 1 ml and then twice with 2 ml of Hanks's balanced salt solution (HBSS) containing 10 mM EDTA, and the exudates were centrifuged at 100 g for 10 min at room temperature. The cells were resuspended in 1 ml of HBSS containing 10 mM EDTA and were stained with Wright's stain to quantify the cell populations.
Neutrophil preparation and culture
Neutrophils were prepared as described previously [21] . In brief, peritoneal exudate cells were obtained from mice inoculated intraperitoneally (i.p.) 10-12 h previously with 1 ml of 10% protease peptone. The cells were resuspended in 1 ml of RPMI-1640 with 10% fetal bovine serum (FBS), layered onto a two-step (54Á8%/70Á2%) discontinuous Percoll gradient, and centrifuged at 1500 g for 30 min at 228C. The cells (> 95% neutrophils, 1 3 10 7 neutrophils/mouse)
were recovered from the lower interface. Neutrophils were cultured in RPMI-1640 with 10% FBS at 378C with 5% CO 2 with or without LPS (10 ng/ml) and TIIA. After treatment, the cells were collected for quantitative real-time PCR (qRT-PCR) and Western blot analysis and the medium was collected for ELISA analysis.
RNA extraction and qRT-PCR analysis
Neutrophils were plated at the density of 5 3 10 6 cells in a six-well plate with 2 ml of culture medium per well. Cells were treated with TIIA at different concentrations and stimulated with LPS (10 ng/ml) at 378C for 2 h. Total RNA was extracted from neutrophils with Trizol (Invitrogen) and 1 lg total RNA was reverse-transcribed to cDNA with ReverTra Ace qPCR RT Master Mix (Toyobo, Osaka, Japan), according to the manufacturer's instructions. The qRT-PCR was performed with SYBR Green real-time PCR Master Mix (Toyobo) and pairs of oligonucleotide primers: IL-6 (sense: CTGCAAGAGACTTCCATCCAG, anti-sense: AGTGGTATAGACAGGTCTGTTGG); TNF-a (sense: ACA GAAAGCATGATCCGCG, anti-sense: GCCCCCCATC TTTTGGG); b-actin (sense: AGAGGGAAATCGTGCGTG AC, anti-sense: CAATAGTGATGACCTGGCCGT). The specificity of the amplified PCR products was assessed by a melting curve analysis. The 2 2DDCT method was used for the calculation of relative expression and the fold induction of gene expression was normalized to beta actin levels.
ELISA analysis
The concentrations of IL-6 and TNF-a were measured using an ELISA kit (Invitrogen), according to the manufacturer's instructions.
Immunofluorescence assay
Neutrophils were seeded at a density of 10 5 cells/well in a 24-well tissue culture plate with flame-sterilized coverslips. The cells were incubated with or without TIIA and phorbol 12-myristate 13-acetate (PMA) (25 nM) for 4 h. The cells were fixed for 15 min in 4% (w/v) paraformaldehyde/(PBS and made permeable by the addition of 0Á25% Triton X-100/PBS for 15 min. Cells were incubated with 1% bovine serum albumin (BSA) in PBS with Tween-20 (PBST) for 30 min to block no specific binding of the antibodies and were then incubated with anti-NE and anti-MPO (diluted in 1% BSA in PBST) in a humidified chamber overnight at 48C. After washing three times, secondary antibodies conjugated with fluorescein were added and incubated for 1Á5 h. The cells were then incubated with 4',6-diamidino-2-phenylindole (DAPI) for 5 min to stain the nuclei. The cells were imaged using a confocal microscope (BX60, Olympus, Tokyo, Japan) and charge-coupled device system.
Western blot analysis
Samples were subjected to electrophoresis on 10% sodium dodecyl sulphate-polyacrylamide gel (SDS-PAGE) and were transferred to nitrocellulose membranes. The membranes were blocked with 5% non-fat dried milk in Trisbuffered saline, 0Á1% Tween 20 (TBST) buffer (137 mM NaCl, 20 mM Tris-HCl, pH 7Á6 and 0Á1% Tween 20) for 2 h and then incubated with primary antibodies at 48C overnight. After washing with TBST three times, the membranes were incubated with HRP-conjugated secondary antibodies (1 : 7500 dilutions) for 1 h at room temperature. Enhanced chemiluminescence (ECL) reagent (GE Healthcare, Chicago, IL, USA) was used for protein detection. Following another triple wash, the proteins were visualized using a chemiluminescence system. The intensities of protein bands in the Western blot were quantified using ImageJ software (National Institutes of Health, Bethesda, MD, USA).
Flow cytometry analysis
Neutrophils were plated at a density of 2 3 10 6 cells in a six-well plate with 2 ml of culture medium per well. Cells were washed twice with cold PBS and then resuspended in 13 binding buffer at a concentration of 1 3 10 6 cells/ml.
One hundred microlitres of the solution (1 3 10 5 cells) was then transferred to a 5-ml culture tube. Fluorescein isothiocyanate (FITC)-annexin V and propidium iodide (PI) (5 ml each) were then added. The cells were then gently vortexed and incubated for 15 min at room temperature (RT) (258C) in the dark, after which 400 ll of 13 binding buffer was added to each tube. The cells were analysed by flow cytometry within 1 h. 
Results
TIIA alleviated RA in mice
In this study, we used a murine model challenged with FCA to examine whether TIIA could prevent joint inflammation. The adjuvant-induced paw oedema was compared with the control mice; it was noted that i.p. injection of TIIA (30 mg/kg/d) reduced paw oedema (Fig.  1a) (n 5 10), ankle joint diameter (Fig. 1b) and arthritis scores significantly (Fig. 1c) . Histological analysis of ankle joints showed that FCA challenge resulted in typical inflammation, characterized by cartilage erosion, synovial hyperplasia and infiltration of multiple types of inflammatory cells compared with normal mice. Treatment with TIIA alleviated the arthritis in mice significantly (Fig. 1d) .
TIIA inhibits MPO and NE expression in the ankle joints of RA mice
The measurement of MPO and NE enzymatic activity is a well-established and defined method for the determination of neutrophil inflammatory function and recruitment to tissue. MPO is a key component of oxidant production in neutrophils, and is also prominent in NETs. Plasma and synovial MPO and its products have been associated strongly with RA severity [22] . Aberrant MPO expression from activated neutrophils amplifies inflammation and causes tissue damage through the formation of reactive intermediates. NE, a type of serine protease, also localizes in NETs via its high affinity for DNA. NE promotes cartilage degradation and plays a role in the proteolytic activation of cytokines and chemokines [23] . We performed immunohistochemical analyses to investigate whether TIIA can reduce MPO and NE expression in RA mice. The MPO and NE expression levels were significantly higher in RA mice compared with the control group. However, TIIA treatment suppressed significantly the MPO and NE upregulation induced by FCA (Fig. 2) .
TIIA inhibited LPS-induced neutrophil influx in vivo
Infiltration of neutrophils into the joints plays important roles in bone erosion and articular destruction in RA [2] . Air pouch experiments were used to investigate the impact of TIIA on LPS-induced neutrophil infiltration. As shown in Fig. 3 , TIIA treatment reduced total leucocyte and neutrophil numbers significantly in the air pouch.
TIIA induced the apoptosis of LPS-treated neutrophils
Apoptosis is essential for the removal of neutrophils from inflamed tissues and the timely resolution of inflammation [24] . However, neutrophils that have migrated into RA joints display a delay in apoptosis and have an enhanced potential to cause host tissue damage due to their extended lifespan [2] . The Bcl-2 protein family, which is divided into pro-apoptotic proteins, such as Bax, and anti-apoptotic proteins, such as Bcl-2, is a central mediator of the intrinsic pathway [25] . Caspase 3 is a critical executor of apoptosis, which is important for both the extrinsic and intrinsic apoptosis pathways, as caspase 3 cleavage is a key step in the activation of apoptosis [26] . To investigate whether the anti-inflammatory effect of TIIA results from promoting neutrophil apoptosis, we detected the expression levels of Bcl-2, Bax and cleaved caspase 3 by Western blot. TIIA increased Bax and cleaved caspase 3 expression significantly, while TIIA treatment reduced Bcl-2 expression (Fig. 4a,b) . Thus, TIIA treatment promoted neutrophil apoptosis. The neutrophil apoptosis was also examined in an annexin V/PI staining assay and via flow cytometry. As shown in Fig. 4c,d , TIIA treatment increased the number of late apoptotic cells significantly.
Effect of TIIA on cytokine production in LPSactivated neutrophils
Neutrophils can express and secrete large varieties of cytokines after activation, such as TNF-a, IL-1b and IL-6. TNF-a has been detected in high concentrations in the serum and synovial fluid of RA patients and plays a pivotal role in RA pathogenesis [8] . IL-6 is a multi-functional cytokine with key roles in inflammation and bone metabolism through the regulation of osteoclast differentiation. Elevated levels of IL-6 have been reported in the serum and synovial fluid of patients with RA and correlate with inflammation and disease severity [8] . We next studied whether TIIA could regulate the cytokine expression profile in neutrophils in vitro. Mouse peritoneal neutrophils were purified and treated with LPS or LPS/TIIA for 2 h. The qRT-PCR analysis showed that TIIA down-regulated TNFa and IL-6 mRNA expression levels significantly in LPSactivated neutrophils (Fig. 5a,b) . Consistently, ELISA analysis showed that TIIA treatment also reduced TNF-a and IL-6 protein secretion significantly in a dose-dependent manner (Fig. 5c,d ). In addition, peritoneal injection of TIIA reversed the elevation of TNF-a and IL-6 in the plasma of RA mice (Fig. 5e,f) .
TIIA inhibited NETs formation and MPO and NE release by neutrophils in vitro
A recently revealed novel feature of neutrophils is their capacity to generate NETs via a distinct process of cell death, termed NETosis. The molecular pathways leading to NETosis include calcium mobilization, generation of reactive oxygen species (ROS) and nuclear delobulation involving the enzymatic activities of MPO and NE. A number of studies have implicated NETs as a source of tissue damage and autoantibody production in RA [13] . NETs externalize various autoantigens and granule enzymes, which may perpetuate a vicious cycle leading to the generation of specific autoantibodies and inflammatory responses. In our study, PMA-induced NETs formation was visualized by staining with DAPI (blue) and anti-MPO (red) or anti-NE (green) and was observed by immunofluorescence confocal microscopy. As shown in Fig. 6 , TIIA inhibited NETs formation, along with NETs-associated MPO and NE release.
Discussion
RA is the most common inflammatory joint disease. The aetiopathogenesis of this disease has been classically explained by a T cell-driven process. However, recent studies have highlighted the significant contribution of neutrophils to RA physiopathology [1, 2] . Neutrophils are the major infiltrating inflammatory cells and serve as a firstline defence against invading microorganisms or tissue injury [22, 23] . If neutrophils infiltrate tissues in large numbers and secrete high levels of cytokines and chemokines, these processes may overwhelm the anti-protease and anti-oxidant protective mechanisms in tissues, which can lead to indiscriminate tissue damage, further stimulating neutrophils infiltration, thus forming a vicious cycle. A large number of activated neutrophils are found in RA synovial fluid and pannus, which play pivotal roles in tissue damage within RA joints. Therefore, neutrophils serve as important targets for RA therapy [27] . TNF-a and IL-6 are essential for neutrophil activation and migration [7, 8] . The signalling of neutrophils to leave the circulation depends upon the up-regulation of ICAM-1 on the surfaces of endothelial cells [28] . The major inducer of ICAM-1 on endothelial cells is TNF-a [29, 30] . Thus, down-regulating TNF-a expression will prevent the first important step in neutrophil emigration and activation. IL-6 mediates similar effects to those of TNF-a in the local synovial environment, with the added role of directly driving the acute-phase response [31] . Neutralizing IL-6 can inhibit the adhesion of neutrophils to co-cultured endothelial cells [32] . Our study showed that TIIA reduced TNF-a and IL-6 expression and secretion significantly.
Neutrophils are characterized by a very short lifespan. In the absence of activating stimuli, neutrophils stay in circulation for 6-18 h before undergoing constitutive apoptosis [33] . Apoptosis is crucial for neutrophil turnover and for the resolution of inflammation. Apoptotic neutrophils are recognized and ingested by macrophages, leading to the production of anti-inflammatory mediators. If there is an impairment in neutrophil clearance, apoptotic neutrophils undergo secondary necrosis. Ingestion of necrotic cellular debris by macrophages induces the production of proinflammatory cytokines, thus amplifying the inflammatory scenario [34] . In patients with early RA, synovial neutrophils show significantly lower levels of apoptosis compared with patients with other persistent forms of arthritis [35] . Therefore, to resolve inflammation, it is essential to promote neutrophil apoptosis in a timely manner in inflamed tissues. Our study also showed that TIIA treatment promoted neutrophil apoptosis by enhancing caspase 3 activity.
NETosis is a distinct death process of neutrophils. NETs externalize various autoantigens and granule enzymes [36, 37] , which perpetuate a vicious cycle leading to the generation of specific autoantibodies and inflammatory responses. In the current study, we found that TIIA inhibited NETs formation significantly, and NETs-associated MPO and NE release.
In conclusion, our study showed that TIIA can ameliorate inflammation in a murine model of RA by targeting neutrophils in three ways. First, TIIA reduced TNF-a and IL-6 expression and secretion, thus inhibiting neutrophil activation and infiltration. Secondly, TIIA promoted neutrophil apoptosis, thus decreasing the numbers of activated neutrophils in the inflamed joints. Thirdly, TIIA inhibited NETs formation and NETs-associated MPO and NE release, thus reducing tissue damage and inflammation. These results indicate that TIIA may act as a potential therapeutic for RA.
